Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins

Author： Egger Sabin S.

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.5, 2007-01, pp. : 429-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

By Straubhaar Bernhard Krähenbühl Stephan Schlienger Raymond G.

Drug Safety, Vol. 29, Iss. 1, 2006-01 ,pp. : 79-90

Adis International

Access to resources Recommend Favorite

Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy

By Bravo Alexandra E. Rätz

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 263-275

Adis International

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Thienopyridines and Statins: Assessing a Potential Drug-Drug Interaction

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1271-1280

Bentham Science Publishers

Access to resources Recommend Favorite

The incidence of potential drug-drug interactions in elderly patients with arterial hypertension

By Bacic-Vrca Vesna

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 815-821

Springer Publishing Company

Access to resources Recommend Favorite